Abstract CT176: ctDNA as a prognostic and pharmacodynamic biomarker following first- or later-line treatment of advanced NSCLC with BNT116 + cemiplimab
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Janet L. Markman, Chiara Dalle Fratte, Chris D. Hermann, Maximilian Tator, Kathrin John, Kezi Ünsal-Kaçmaz, Victoria Chen, Manas Kumar Rout, Felicitas Tissen, Malgorzata Kaczorowska, Israel Lowy, Frank Seebach, Bala Başak Öven, Dániel Deme, Patrick Forde, Akin Atmaca, Michael Wenger, Özlem Türeci, Uğur Şahin, Patrick Brück, Rafal Dziadziuszko
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154680446